CRISPR NEWS

U.S. Patent and Trademark Office issued 3rd CRISPR patent to CVC; indicates it will issue a 4th

On March 12, 2019 the U.S. Patent and Trademark Office issued U.S. Patent No.  (‘the ‘611 patent), to The Regents of the University of California, the University of Vienna, and Dr. Emmanuelle Charpentier (collectively, “CVC”). The patent covers the use of single guide RNA formats in any setting. The ‘611 patent claims earliest priority to a U.S. provisional application, filed by CVC on May 25, 2012.

View Press Release

LATEST

Sign up to receive updates from the CRISPR Collective

Related News

U.S. Patent and Trademark Office issues 9th and 10th CRISPR patents to CVC July 23, 2019
U.S. Patent and Trademark Office issues 8th CRISPR patent to CVC July 16, 2019
U.S. Patent and Trademark Office issues 7th CRISPR patent to CVC July 2, 2019
Read moreArrow-down